Evidence map›Paper›PMID 31501931›Full record

ArticleEJNMMI research2019

In vivo imaging of early stages of rheumatoid arthritis by α5β1-integrin-targeted positron emission tomography.

Johannes Notni, Florian T Gassert, Katja Steiger, Peter Sommer, Wilko Weichert, Ernst J Rummeny, Markus Schwaiger, Horst Kessler, Reinhard Meier, Melanie A Kimm

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Johannes NotniInstitute of Pathology, Technische Universität München, Trogerstr. 18, 81675, Munich, Germany. johannes.notni@tum.de.ORCID http://orcid.org/0000-0002-3964-3391
Florian T GassertDepartment of Diagnostic and Interventional Radiology, Technische Universität München, Munich, Germany.
Katja SteigerInstitute of Pathology, Technische Universität München, Trogerstr. 18, 81675, Munich, Germany.
Peter SommerDepartment of Diagnostic and Interventional Radiology, Technische Universität München, Munich, Germany.
Wilko WeichertInstitute of Pathology, Technische Universität München, Trogerstr. 18, 81675, Munich, Germany.
Ernst J RummenyDepartment of Diagnostic and Interventional Radiology, Technische Universität München, Munich, Germany.
Markus SchwaigerDepartment of Nuclear Medicine, Technische Universität München, Munich, Germany.
Horst KesslerInstitute for Advanced Study, Department of Chemistry, Technische Universität München, Garching, Germany.
Reinhard MeierDepartment of Diagnostic and Interventional Radiology, Technische Universität München, Munich, Germany.
Melanie A KimmDepartment of Diagnostic and Interventional Radiology, Technische Universität München, Munich, Germany.
TUM Klinikum · DEDeutschen Konsortium für Translationale Krebsforschung · DETechnical University of Munich · DEInstitute for Advanced Study · DE

Funding

Deutsche Forschungsgemeinschaft ME3718/2-1Deutsche Forschungsgemeinschaft ME3718/5-1Deutsche Forschungsgemeinschaft NO822/4-1Deutsche Forschungsgemeinschaft SFB 824, Project A10Deutsche Forschungsgemeinschaft SFB 824, Project Z2
6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) is one of the most common rheumatic diseases. Joint inflammation and pathological growth of joint cartilage cause swollen and painful joints, which severely diminishes the patients' life quality. There is no causal treatment. Symptomatic therapies should start as early as possible to take maximal effect. Hence, diagnostic procedures capable of detecting affected joints before the onset of clinical symptoms are highly desirable. We explored the value of PET imaging of integrin subtypes αvβ3 and α5β1 for early detection of RA foci in collagen-induced arthritis (CIA) mouse models.

resultsDevelopment of RA in CIA mice was monitored by paw scoring, and αvβ3- and α5β1-integrin expression was quantified by μPET using

conclusionα5β1-integrin PET could add a new functional imaging aspect to the portfolio of RA diagnostics because it appears to be a sensitive biomarker for early RA development. We suggest α5β1-integrin PET as a valuable tool to achieve a higher precision for early diagnosis of RA, including initial staging, monitoring of the disease course, and drug treatment, and for planning of radiosynoviorthesis (RSO).

Indexed as

Animal modelsCollagen-induced arthritisImmunohistochemistryIntegrinsPositron emission tomographyRheumatoid arthritis

Identifiers

PMID31501931
PMCPMC6733939
OpenAlexW2972720945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.